Revolution Medicines (RVMD) Change in Receivables (2019 - 2024)
Revolution Medicines' quarterly Change in Receivables came in at -$1.3 million in Q1 2024, down 84.96% year-on-year from -$8.3 million in Q2 2023, and down 232.7% quarter-over-quarter from $945000.0 in Q4 2023.
Revolution Medicines has reported Change in Receivables for 6 years, with the latest figure at -$1.3 million in Q1 2024.
- For the quarter ending Q1 2024, Change in Receivables fell 84.96% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2024 stood at -$1.3 million (up 63.32% YoY), and the FY2024 full-year result was -$1.3 million, up 63.32% from the prior year.
- Change in Receivables for Q1 2024 stood at -$1.3 million, down from $945000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.0 million in Q3 2020, with the low at -$2.9 million in Q4 2020.
- Average Change in Receivables over 5 years is -$513941.2, with a median of -$678000.0 recorded in 2023.
- Peak annual rise in Change in Receivables reached 2975.0% in 2020, while the deepest fall reached 1264.32% in 2020.
- Tracing RVMD's Change in Receivables over 5 years: stood at -$2.9 million in 2020, then soared by 48.97% to -$1.5 million in 2021, then soared by 82.0% to -$267000.0 in 2022, then surged by 453.93% to $945000.0 in 2023, then tumbled by 232.7% to -$1.3 million in 2024.
- The last three Change in Receivables figures came in at -$1.3 million (Q1 2024), $945000.0 (Q4 2023), and -$2.2 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.25 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 945,000.00 |
| Dec 31, 2023 | 945,000.00 |
| Sep 30, 2023 | -2.20 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Mar 31, 2023 | -678,000.00 |
| Mar 31, 2023 | -678,000.00 |
| Dec 31, 2022 | -267,000.00 |
| Dec 31, 2022 | -267,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | -546,000.00 |
| Mar 31, 2022 | -546,000.00 |
| Dec 31, 2021 | -1.48 Mn |
| Dec 31, 2021 | -1.48 Mn |
| Sep 30, 2021 | 885,000.00 |
| Sep 30, 2021 | 885,000.00 |
| Jun 30, 2021 | -1.04 Mn |
| Jun 30, 2021 | -1.04 Mn |
| Mar 31, 2021 | 1.17 Mn |
| Mar 31, 2021 | 1.17 Mn |
| Dec 31, 2020 | -2.91 Mn |
| Dec 31, 2020 | -2.91 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Jun 30, 2020 | -1.12 Mn |
| Jun 30, 2020 | -1.12 Mn |
| Mar 31, 2020 | -287,000.00 |
| Mar 31, 2020 | -287,000.00 |
| Dec 31, 2019 | -213,000.00 |
| Dec 31, 2019 | -213,000.00 |
| Sep 30, 2019 | 64,000.00 |
| Sep 30, 2019 | 64,000.00 |
| Jun 30, 2019 | 954,000.00 |
| Jun 30, 2019 | 954,000.00 |
| Mar 31, 2019 | 629,000.00 |
| Mar 31, 2019 | 629,000.00 |